Central serous chorioretinopathy and the sclera: what we have learned so far

被引:4
|
作者
Koizumi, Hideki [1 ]
Imanaga, Naoya [1 ]
Terao, Nobuhiro [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Ophthalmol, 207 Uehara, Nishihara, Okinawa 9030215, Japan
关键词
Central serous chorioretinopathy; Pachychoroid; Sclera; Uveal effusion syndrome; Vortex vein; INDOCYANINE GREEN ANGIOGRAPHY; PHOTODYNAMIC THERAPY; VORTEX VEIN; THICKNESS; LOCULATION; FEATURES; EFFUSION; FLUID;
D O I
10.1007/s10384-024-01101-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Central serous chorioretinopathy (CSC) is a common disorder characterized by serous retinal detachment. Several studies using indocyanine green angiography (ICGA) have revealed that choroidal filling delay, choroidal vascular dilation, and choroidal vascular hyperpermeability are the characteristic findings of CSC. These ICGA findings confirm that choroidal circulatory disturbances are the primary factors in the pathogenesis of CSC. With advancements in optical coherence tomography (OCT), choroidal thickness has been found to be significantly greater in eyes with CSC than in normal eyes. Dilated large choroidal vessels reportedly account for the thickened choroid in eyes with CSC. Although many possible mechanisms and risk factors have been suggested, the pathophysiologic features of choroidal circulatory disturbances and choroidal thickening in eyes with CSC have not yet been fully elucidated. Recently, using anterior segment OCT, we proposed that the sclera may induce choroidal circulatory disturbances since CSC eyes have significantly thicker sclera than do normal eyes. This review summarizes updated information on the close relationship between CSC pathogenesis and the sclera.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 18 条
  • [1] Central serous chorioretinopathy: what we have learnt so far
    Wong, Kah Hie
    Lau, Kin Pong
    Chhablani, Jay
    Tao, Yong
    Li, Qing
    Wong, Ian Y.
    ACTA OPHTHALMOLOGICA, 2016, 94 (04) : 321 - 325
  • [2] Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy
    Goldhagen B.E.
    Goldhardt R.
    Current Ophthalmology Reports, 2017, 5 (2) : 141 - 148
  • [3] Autoimmune thyroiditis and central serous chorioretinopathy may have a relation
    Takkar, Brijesh
    Saxena, Harsha
    Rathi, Anubha
    Singh, Rekha
    MEDICAL HYPOTHESES, 2018, 121 : 180 - 182
  • [4] DOES MICROPERIMETRY HAVE A PROGNOSTIC VALUE IN CENTRAL SEROUS CHORIORETINOPATHY?
    Roisman, Luiz
    Ribeiro, Joao C.
    Fechine, Francisco V.
    Lavinsky, Daniel
    Moraes, Nilva
    Campos, Mauro
    Farah, Michel E.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (04): : 713 - 718
  • [5] The inner segment/outer segment junction: what have we learnt so far?
    Wong, Ian Y.
    Iu, Lawrence P.
    Koizumi, Hideki
    Lai, Wico W.
    CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (03) : 210 - 218
  • [6] Patients with central serous chorioretinopathy not only have pachychoroidal disorders but also altered retinal metabolic function
    Tschuppert, Scott
    Valmaggia, Christophe
    Todorova, Margarita G.
    ACTA OPHTHALMOLOGICA, 2022, 100 (07) : E1395 - E1402
  • [7] Imaging and classification of central serous chorioretinopathy-What do I really need?
    Pauleikhoff, Laurenz
    Hufnagel, Hinrich
    Lange, Clemens
    OPHTHALMOLOGIE, 2025, 122 (03): : 172 - 177
  • [8] What have we learned from research on the "geometric module"?
    Newcombe, Nora S.
    LEARNING & BEHAVIOR, 2024, 52 (01) : 14 - 18
  • [9] Eosinophilic Esophagitis-What Do We Know So Far?
    Wasik, Jakub
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [10] Experimental Therapies for Ebola Virus Disease: What Have We Learned?
    Hayden, Frederick G.
    Friede, Martin
    Bausch, Daniel G.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (02) : 167 - 170